press releases

Lysogene hosts the first European workshop for neuropsychologists to discuss assessment tools in MPS IIIA
Lysogene hosts the first European workshop for neuropsychologists to discuss assessment tools in MPS IIIA 150 150 Lysogene

Monday, March 16 Seven neuropsychologists and metabolic specialists from six countries met to address specific…

Lysogene was invited to present at the Leerink global healthcare conference
Lysogene was invited to present at the Leerink global healthcare conference 150 150 Lysogene

Wednesday, February 11 Karen Aiach, CEO of Lysogene, presented the development strategy and insight of…

Lysogene, University Of Massachusetts Medical School And Auburn University Announce Collaboration Agreement
Lysogene, University Of Massachusetts Medical School And Auburn University Announce Collaboration Agreement 150 150 Lysogene

Tuesday, February 10 LYSOGENE, a leading, clinical stage gene therapy biotechnology company committed to the…

Lysogene was invited to give a platform presentation at the world conference in Orlando
Lysogene was invited to give a platform presentation at the world conference in Orlando 150 150 Lysogene

Thursday, February 12 LYSOGENE  has been invited to give a platform presentation “AAVrh10-SGSH intracerebral gene…

Lysogene COVID-19 update

Find out More

Lysogene is developing therapies for children with CNS diseases.

Delivering Gene Therapy’s Promise

About Us
Our Science
Meet the Team
Diseases
Resources

Contact Us
Careers
Transparency
Compassionate Use Policy

©2022 Lysogene. All rights reserved.

Cookie Policy
Privacy Policy
Legal Notice

Get In Touch

Don’t hesitate to contact us if you need more help.

    Start Typing